ProShare Advisors
CABA icon

ProShare Advisors’s Cabaletta Bio CABA Stock Holding History

ProShare Advisors’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-12,637
Closed -$28.7K – 2115
2024
Q4 		$28.7K Buy
12,637
+1,372
+12% +$4.82K ﹤0.01% 2237
2024
Q3 		$53.2K Buy
+11,265
New +$65.2K ﹤0.01% 1973

Other funds holding CABA

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

ProShare Advisors's CABA Position: Q1 2025 in Review

ProShare Advisors sold out of Cabaletta Bio (CABA) in Q1 2025, closing a stake of 12,637 shares — an estimated $28.7K sold.

ProShare Advisors first reported a position in CABA in Q3 2024 and held it in 2 quarters. The position peaked at $53.2K in Q3 2024. 92 funds tracked by Wall St. Rank hold CABA as of Q1 2025.

  • ProShare Advisors reported no remaining Cabaletta Bio position as of Q1 2025 after selling out during the quarter.
  • ProShare Advisors sold 12,637 Cabaletta Bio shares in Q1 2025, an estimated $28.7K.
  • ProShare Advisors first reported a position in Cabaletta Bio in Q3 2024 and held it in 2 quarters.
  • ProShare Advisors's Cabaletta Bio position peaked at $53.2K in Q3 2024.
  • 92 funds tracked by Wall St. Rank held Cabaletta Bio as of Q1 2025.

Based on ProShare Advisors's 13F filing for Q1 2025, filed 8 May 2025.